MIAMI BEACH, Fla., April 27, 2018 -- via OTC PR WIRE -- SNM Global Holdings (OTC:SNMN) is excited to announce the assembly of a group of medical cannabis industry experts from the financial, medical, and legal sectors.
During the recent legislative session in the Maryland legislature, a bill was passed to authorize the Maryland Medical Cannabis Commission to reopen the application process and grant several additional Medical Cannabis Grower and Processor licenses throughout the state. We will be working diligently over the next several months to complete the application process, identify key areas within the state of Maryland for suitable facilities, and engage horticulture experts, as well as seasoned medical operations personnel to position SNM to be awarded either one or both of these new license opportunities.
"SNM is excited to have become involved with industry experts in each stage of the medical cannabis arena, from grow operations all the way down to retail sales at the dispensary level," stated SNM CEO Troy Lowman, "the legal counsel we have retained to assist us with our Grower and Processing applications to the Maryland Medical Cannabis Commission has a proven track record of assisting their clients in acquiring various medical cannabis licenses." “It is very humbling to realize we will be a part of a rapidly developing industry that will help so many people achieve quality of life living while with cancer and so many other diseases,” says Lowman.
The process from application to becoming fully operational is expected to take approximately 365 days.
Contact Information
Troy Lowman, CEO
Phone (410)733-6551
Email: [email protected]
Safe Harbor for Forward-Looking Statements. This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company’s current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company’s business prospect s and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commissions. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.


Anduril Eyes $60 Billion Valuation in New Funding Round to Expand Defense Manufacturing and Autonomous Fighter Jet Development
Thomas Pritzker to Step Down as Hyatt Executive Chairman After Epstein Ties Acknowledged
Disney Issues Cease-and-Desist to ByteDance Over Alleged AI Copyright Infringement
Treasury Wine Estates Profit Falls 46% as China and U.S. Inventory Reset Weighs on Earnings
Bank of America CEO Brian Moynihan’s 2025 Compensation Rises 17% to $41 Million Amid Strong Profit Growth
Vietnam Approves SpaceX Starlink Satellite Internet Service Amid U.S. Trade Talks
BlueScope Steel Forecasts Stronger Second-Half Earnings, Shares Rise Above Rejected Buyout Offer
Lockheed Martin Secures $101M in U.S. Defense Contracts for AEGIS, F-35, and Missile Systems
Ireland’s Data Protection Commission Launches GDPR Investigation Into X’s AI Chatbot Grok
Sachem Head Boosts Warner Bros. Discovery Stake Amid Netflix Deal and Paramount Bid
OpenAI Hires OpenClaw Creator Peter Steinberger to Advance Next-Generation AI Agents
Warner Bros. Discovery Weighs Renewed Sale Talks With Paramount Skydance Amid Netflix Deal Review
Goldman Sachs Reportedly Drops Diversity Criteria From Board Candidate Evaluations
Anderson Cooper to Exit CBS News’ 60 Minutes After Nearly 20 Years
Freedom Finance and Binance Join Forces in Digital Assets
Santos Wins Court Case Over Net Zero and Sustainability Claims 



